1. Home
  2. AMLX vs SVM Comparison

AMLX vs SVM Comparison

Compare AMLX & SVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amylyx Pharmaceuticals Inc.

AMLX

Amylyx Pharmaceuticals Inc.

HOLD

Current Price

$19.37

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Silvercorp Metals Inc.

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$9.29

Market Cap

2.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMLX
SVM
Founded
2014
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
AMLX
SVM
Price
$19.37
$9.29
Analyst Decision
Strong Buy
Hold
Analyst Count
9
1
Target Price
$21.56
$10.50
AVG Volume (30 Days)
1.6M
2.3M
Earning Date
05-07-2026
05-25-2026
Dividend Yield
N/A
0.22%
EPS Growth
65.46
N/A
EPS
N/A
N/A
Revenue
$380,786,000.00
N/A
Revenue This Year
N/A
$36.87
Revenue Next Year
N/A
$35.34
P/E Ratio
N/A
N/A
Revenue Growth
1612.94
N/A
52 Week Low
$7.48
$4.29
52 Week High
$20.90
$15.77

Technical Indicators

Market Signals
Indicator
AMLX
SVM
Relative Strength Index (RSI) 59.66 44.06
Support Level $12.14 $8.68
Resistance Level N/A $10.19
Average True Range (ATR) 1.28 0.45
MACD 0.13 0.09
Stochastic Oscillator 68.10 47.93

Price Performance

Historical Comparison
AMLX
SVM

About AMLX Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.

Share on Social Networks: